p21^Waf1/Cip1 Inhibition of Cyclin E/Cdk2 Activity Prevents Endoreduplication after Mitotic Spindle Disruption

REFERENCES

• Arellano, M., and J. Moreno 1997. Regulation of CDK/cyclin complexes during the cell cycle. Int. J. Biochem. Cell Biol. 29:559–573.
   PubMed Web of Science ®Google Scholar
• Chellappan, S. P., S. Hiebert, M. Mudryj, J. M. Horowitz, and J. Nevins 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053–1061.
   PubMed Web of Science ®Google Scholar
• Chen, J., P. K. Jackson, M. W. Kirschner, and J. Dutta 1995. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374:386–388.
   PubMed Web of Science ®Google Scholar
• Chen, J., T. Willingham, M. Shuford, D. Bruce, E. Rushing, Y. Smith, and J. Nisen 1996. Effects of ectopic overexpression of p21WAF1/CIP1 on aneuploidy and the malignant phenotype of human brain tumor cells. Oncogene 13:1395–1403.
   PubMedGoogle Scholar
• Cohen-Fix, O., and J. Koshland 1997. The metaphase-to-ananphase transition: avoiding a mid-life crisis. Curr. Opin. Cell Biol. 9:800–806.
   PubMedGoogle Scholar
• Cross, S. M., C. A. Sanchez, C. A. Morgan, M. K. Schimke, S. Ramel, R. L. Idzerda, W. H. Raskind, and J. Reid 1995. A p53-dependent mouse spindle checkpoint. Science 267:1353–1356.
   PubMed Web of Science ®Google Scholar
• Di Leonardo, A., S. H. Khan, S. P. Linke, V. Greco, G. Seidita, and J. Wahl 1997. DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res. 57:1013–1019.
   PubMed Web of Science ®Google Scholar
• Dulic, V., E. Lees, and J. Reed 1992. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257:1958–1961.
   PubMed Web of Science ®Google Scholar
• El-Deiry, W. S., J. W. Harper, P. M. O’Connor, V. E. Velculescu, C. E. Canman, J. Jackman, J. A. Pietenpol, M. Burrell, D. E. Hill, Y. Wang, K. G. Wiman, W. E. Mercer, M. B. Kastan, K. W. Kohn, S. J. Elledge, K. W. Kinzler, and J. Vogelstein 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1169–1174.
   PubMed Web of Science ®Google Scholar
• El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and J. Vogelstein 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817–825.
   PubMed Web of Science ®Google Scholar
• Gorbsky, G. J. 1997. Cell cycle checkpoints: arresting progress in mitosis. Bioessays 19:193–197.
   PubMedGoogle Scholar
• Gu, Y., C. W. Turck, and J. Morgan 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707–710.
   PubMed Web of Science ®Google Scholar
• Hannon, G. J., and J. Beach 1994. p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257–261.
   PubMed Web of Science ®Google Scholar
• Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and J. Elledge 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805–816.
   PubMed Web of Science ®Google Scholar
• Hartwell, L. 1992. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71:543–546.
   PubMed Web of Science ®Google Scholar
• Hartwell, L. H., and J. Kastan 1994. Cell cycle control and cancer. Science 266:1821–1828.
   PubMed Web of Science ®Google Scholar
• Hartwell, L. H., and J. Weinert 1989. Checkpoints: controls that ensure the order of cell cycle events. Science 246:629–634.
   PubMed Web of Science ®Google Scholar
• Helin, K., and J. Harlow 1993. The retinoblastoma protein as a transcriptional repressor. Trends Cell Biol. 3:43–46.
   PubMedGoogle Scholar
• Hiebert, S. W., S. Chellappan, J. M. Horowitz, and J. Nevins 1992. The interaction of RB with E2F coincides with inhibition of the transcriptional activity of E2F. Genes Dev. 6:177–185.
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and J. Weinberg 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993–1006.
   PubMed Web of Science ®Google Scholar
• Hirai, H., M. F. Roussel, J.-Y. Kato, R. A. Ashmun, and J. Sherr 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15:2672–2681.
   PubMed Web of Science ®Google Scholar
• Hoyt, M. A., L. Totis, and J. Roberts 1991. S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell 66:507–517.
   PubMed Web of Science ®Google Scholar
• Hunter, T., and J. Pines 1994. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79:573–582.
   PubMed Web of Science ®Google Scholar
• Kamb, A., N. A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S. V. Tavtigian, E. Stockert, R. S. Day III, B. E. Johnson, and J. Skolnick 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436–440.
   PubMed Web of Science ®Google Scholar
• Khan, S. H., and J. Wahl 1998. p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest. Cancer Res. 58:396–401.
   PubMedGoogle Scholar
• Koff, A., A. Giordano, D. Desai, K. Yamashita, J. W. Harper, S. Elledge, T. Nishimoto, D. O. Morgan, B. R. Franza, and J. Roberts 1992. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257:1689–1694.
   PubMed Web of Science ®Google Scholar
• Lanni, J. S., and J. Jacks 1998. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell Biol. 18:1055–1064.
   PubMed Web of Science ®Google Scholar
• Lee, M.-H., I. Reynisdóttir, and J. Massagué 1995. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9:639–649.
   PubMed Web of Science ®Google Scholar
• Li, Y., C. W. Jenkins, M. A. Nichols, and J. Xiong 1994. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9:2261–2268.
   PubMed Web of Science ®Google Scholar
• Luo, Y., J. Hurwitz, and J. Massagué 1995. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375:159–161.
   PubMed Web of Science ®Google Scholar
• Matsuoka, S., M. C. Edwards, C. Bai, S. Parker, P. Zhang, A Baldini, J. W. Harper, and J. Elledge 1995. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:650–662.
   PubMed Web of Science ®Google Scholar
• Meyerson, M., and J. Harlow 1994. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077–2086.
   PubMed Web of Science ®Google Scholar
• Minn, A. J., L. H. Boise, and J. Thompson 1996. Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev. 10:2621–2631.
   PubMed Web of Science ®Google Scholar
• Mitsudomi, T., S. M. Steinberg, M. M. Nau, D. Carbone, D. D’Amico, S. Bodner, H. K. Oie, R. I. Linnoila, J. L. Mulshine, J. D. Minna, and J. Gazdar 1992. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7:171–180.
   PubMed Web of Science ®Google Scholar
• Moreno, S., J. Hayles, and J. Nurse 1989. Regulation of p34cdc2 protein kinase during mitosis. Cell 58:361–372.
   PubMed Web of Science ®Google Scholar
• Morgan, D. O. 1995. Principles of CDK regulation. Nature 374:131–134.
   PubMed Web of Science ®Google Scholar
• Myöhänen, S. K., S. B. Baylin, and J. Herman 1998. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res. 58:591–593.
   PubMed Web of Science ®Google Scholar
• Niculescu, A. B. III, X. B. Chen, M. Smeets, L. Hengst, C. Prives, and J. Reed 1998. Effects of p21Cip1/Waf1 at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18:629–643.
   PubMed Web of Science ®Google Scholar
• Nurse, P. 1990. Universal control mechanism regulating onset of M-phase. Nature 344:503–508.
   PubMed Web of Science ®Google Scholar
• Ohtsubo, M., A. M. Theodoras, J. Schumacher, J. M. Roberts, and J. Pagano 1995. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 15:2612–2624.
   PubMed Web of Science ®Google Scholar
• Paulovich, A. G., D. P. Toczyski, and J. Hartwell 1997. When checkpoints fail. Cell 88:315–321.
   PubMed Web of Science ®Google Scholar
• Pellegata, N. S., R. J. Antoniono, J. L. Redpath, and J. Stanbridge 1996. DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc. Natl. Acad. Sci. USA 93:15209–15214.
   PubMed Web of Science ®Google Scholar
• Pines, J., and J. Hunter 1989. Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 58:833–846.
   PubMed Web of Science ®Google Scholar
• Polyak, K., J. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and J. Koff 1994. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9–22.
   PubMed Web of Science ®Google Scholar
• Polyak, K., M.-H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massague 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59–66.
   PubMed Web of Science ®Google Scholar
• Reed, S. I. 1992. The role of p34 kinases in the G1 to S-phase transition. Annu. Rev. Cell Biol. 8:529–561.
   PubMedGoogle Scholar
• Schwarz, J. K., S. H. Devoto, E. J. Smith, S. P. Chellappan, L. Jakoi, and J. Nevins 1993. Interactions of the p107 and Rb proteins with E2F during the cell proliferation response. EMBO J. 12:1013–1020.
   PubMed Web of Science ®Google Scholar
• Serrano, M., G. J. Hannon, and J. Beach 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704–707.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551–555.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. Roberts 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149–1163.
   PubMed Web of Science ®Google Scholar
• Solomon, M. J., J. W. Harper, and J. Shuttleworth 1993. CAK, the p34cdc2 activating kinase, contains a protein identical or closely related to p40MO15. EMBO J. 12:3133–3142.
   PubMed Web of Science ®Google Scholar
• Sorger, P. K., M. Dobles, R. Tournebize, and J. Hyman 1997. Coupling cell division and cell death to microtubule dynamics. Curr. Opin. Cell Biol. 9:807–814.
   PubMed Web of Science ®Google Scholar
• Toyoshima, H., and J. Hunter 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67–74.
   PubMed Web of Science ®Google Scholar
• Tsai, L., E. Lees, B. Faha, E. Harlow, and J. Riabowol 1993. The cdk2 kinase is required for the G1-to-S-phase transition in mammalian cells. Oncogene 8:1593–1602.
   PubMed Web of Science ®Google Scholar
• Waga, S., G. J. Hannon, D. Beach, and J. Stillman 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574–578.
   PubMed Web of Science ®Google Scholar
• Waldmann, T., K. W. Kinzler, and J. Vogelstein 1995. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55:5187–5195.
   PubMedGoogle Scholar
• Wang, J. Y. 1997. Retinoblastoma protein in growth suppression and death protection. Curr. Opin. Genet. Dev. 7:39–45.
   PubMedGoogle Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330.
   PubMed Web of Science ®Google Scholar
• Xiong, Y. 1996. Why are there so many CDK inhibitors? Biochim. Biophys. Acta Rev. Cancer 1288:1–5.
   Google Scholar
• Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and J. Beach 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701–704.
   PubMed Web of Science ®Google Scholar
• Xiong, Y., H. Zhang, and J. Beach 1992. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505–514.
   PubMed Web of Science ®Google Scholar
• Xiong, Y., H. Zhang, and J. Beach 1993. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7:1572–1583.
   PubMed Web of Science ®Google Scholar
• Zhang, H., Y. Xiong, and J. Beach 1993. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell 4:897–906.
   PubMed Web of Science ®Google Scholar